Rockeby Biomed has executed a memorandum of understanding with KanChan International for the exclusive sales, marketing and distribution of Rockeby’s Candia5 Rapid Test Kit throughout India.
Candia5 is a non-invasive rapid test for thrush.
KanChan holds considerable market share in India and has a wide network of depots spread around the country.
It will be marketing the product as a point-of-care test kit to pathology and microbiology laboratories, medical practitioners and allied health professionals across India.
KanChan will be responsible for product registration and expects to commence sales in the first quarter of 2005.
The Candia5 kit is already available in Singapore, Malaysia, Hong Kong, Vietnam, Australia and New Zealand.
Rockeby managing director Sze Wee Tan said the product was the only one of its kind in the world.
"This agreement expands our position in the Asian region and helps establish us as one of the leaders in the development of methods to diagnose and allow effective treatment of fungal infections in people," Dr Tan said.